SUVAXYN PARVO ST SUSPENSION FOR INTRAMUSCULAR INJECTION FOR PIGS

Ülke: İrlanda

Dil: İngilizce

Kaynak: HPRA (Health Products Regulatory Authority)

Aktif bileşen:

PORCINE PARVOVIRUS, STRAIN NADL-2, INACTIVATED

Mevcut itibaren:

Zoetis Ireland Limited

ATC kodu:

QI09AA02

INN (International Adı):

PORCINE PARVOVIRUS, STRAIN NADL-2, INACTIVATED

Doz:

Unknown

Farmasötik formu:

Suspension for Injection

Reçete türü:

LM-Licensed Merchant

Terapötik grubu:

Porcine

Terapötik alanı:

Porcine parvovirus vaccine

Terapötik endikasyonlar:

Immunological - Inactivated vaccine

Yetkilendirme durumu:

Authorised

Yetkilendirme tarihi:

2013-12-09

Ürün özellikleri

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Suvaxyn Parvo ST suspension for intramuscular injection for pigs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Suspension for injection.
Clear pink suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Pigs of a minimum age of 6 months (gilts and sows).
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Active immunisation of sows and gilts to reduce transplacental infection of progeny with porcine parvovirus.
Onset of immunity: 8 weeks after primary vaccination.
Duration of immunity: 4 months after primary vaccination.
4.3 CONTRAINDICATIONS
None.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
In case of a return to service, a booster vaccination should be considered.
Quantitative composition (2 ml dose)
ACTIVE SUBSTANCES:
Inactivated porcine parvovirus,
Antibody titre by Haemagglutination Inhibi-
strain NADL-2
tion (HI) in vaccinated rabbits
368 GMT*
ADJUVANT:
Carbopol #941
2.0 mg
EXCIPIENTS:
Thiomersal
0.17 mg
* Geometric Mean Titre
For the full list of excipients, see section 6.1
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 13/01/2016_
_CRN 7022518_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Vaccinate only clinically healthy animals.
Avoid stress in the animal around the time of injection.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS
In case of accidental self-administration, seek medical advice immediately and show the package leaflet or the label to
the physician.
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
Mild, transient local reactions, including slight visible redness, and slight vis